Lantern Pharma Inc (LTRN)
6.06
-0.24
(-3.81%)
USD |
NASDAQ |
May 31, 16:00
6.10
+0.04
(+0.66%)
After-Hours: 20:00
Lantern Pharma Price to Book Value: 1.823 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 31, 2024 | 1.823 |
May 30, 2024 | 1.895 |
May 29, 2024 | 1.808 |
May 28, 2024 | 1.859 |
May 24, 2024 | 1.886 |
May 23, 2024 | 1.874 |
May 22, 2024 | 1.943 |
May 21, 2024 | 1.889 |
May 20, 2024 | 1.751 |
May 17, 2024 | 1.814 |
May 16, 2024 | 1.847 |
May 15, 2024 | 1.904 |
May 14, 2024 | 1.862 |
May 13, 2024 | 1.832 |
May 10, 2024 | 1.853 |
May 09, 2024 | 2.049 |
May 08, 2024 | 1.949 |
May 07, 2024 | 1.931 |
May 06, 2024 | 2.061 |
May 03, 2024 | 1.85 |
May 02, 2024 | 1.652 |
May 01, 2024 | 1.621 |
April 30, 2024 | 1.534 |
April 29, 2024 | 1.483 |
April 26, 2024 | 1.654 |
Date | Value |
---|---|
April 25, 2024 | 1.642 |
April 24, 2024 | 1.618 |
April 23, 2024 | 1.736 |
April 22, 2024 | 1.721 |
April 19, 2024 | 1.606 |
April 18, 2024 | 1.736 |
April 17, 2024 | 1.802 |
April 16, 2024 | 1.805 |
April 15, 2024 | 1.796 |
April 12, 2024 | 1.922 |
April 11, 2024 | 2.006 |
April 10, 2024 | 2.328 |
April 09, 2024 | 2.334 |
April 08, 2024 | 2.343 |
April 05, 2024 | 2.334 |
April 04, 2024 | 2.172 |
April 03, 2024 | 2.599 |
April 02, 2024 | 2.752 |
April 01, 2024 | 2.861 |
March 28, 2024 | 2.311 |
March 27, 2024 | 2.568 |
March 26, 2024 | 2.634 |
March 25, 2024 | 2.605 |
March 22, 2024 | 2.796 |
March 21, 2024 | 2.371 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5936
Minimum
Oct 31 2023
173.31
Maximum
Jun 11 2020
4.07
Average
1.127
Median
Price to Book Value Benchmarks
Eyenovia Inc | 23.95 |
Cassava Sciences Inc | 13.46 |
Alpine Immune Sciences Inc (DELISTED) | 13.40 |
Clearside Biomedical Inc | -- |
Poseida Therapeutics Inc | 3.427 |
Price to Book Value Related Metrics
Price | 6.06 |
Earnings Yield | -26.90% |
Market Cap | 65.20M |